Drug susceptibility of Brazilian strains of Mycobacterium bovis using traditional and molecular techniques

Detalhes bibliográficos
Autor(a) principal: Parreiras,Patrícia M
Data de Publicação: 2004
Outros Autores: Lobato,Francisco CF, Alencar,Andréa P, Figueiredo,Telma de, Gomes,Harrison M, Boéchat,Neio, Lage,Andrey P, Assis,Ronnie A, Pereira,Márcia AS, Souza,Patrícia R, Mota,Pedro MPC, Suffys,Philip N
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Memórias do Instituto Oswaldo Cruz
Texto Completo: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762004000700015
Resumo: Transmission of Mycobacterium bovis from cattle to humans has been reported and can cause tuberculosis (Tb) and a problem in certain risk populations. Therefore, knowledge of resistance of M. bovis towards antibiotics used for therapy of human Tb could help avoiding cure delay and treatment cost increase when dealing with drug resistant organisms. We therefore evaluated the susceptibility of M. bovis isolates towards streptomycin, isoniazide, rifampicin, ethambutol, and ethionamide, the first line antibiotics for human Tb. Therefore, 185 clinical samples from cattle with clinical signs of tuberculosis were processed and submitted to culturing and bacterial isolates to identification and drug susceptibility testing using the proportion method. Among 89 mycobacterial strains, 65 were identified as M. bovis and none were resistant to any of the antibiotics used. Confirmation of present results by future studies, enrolling a large number of isolates and designed to properly represent Brazilian regions, may favor the idea of using isoniazide preventive therapy as part of a Tb control strategy in special situations. Also, nucleic acids from bacterial isolates were submitted to rifoligotyping, a recently described reverse hybridization assay for detection of mutations causing resistance towards rifampicin. Concordance between the conventional and the molecular test was 100%, demonstrating the use of such methodology for rapid evaluation of drug susceptibility in M. bovis.
id FIOCRUZ-4_a138491662689ae8eaff2b129c7c4421
oai_identifier_str oai:scielo:S0074-02762004000700015
network_acronym_str FIOCRUZ-4
network_name_str Memórias do Instituto Oswaldo Cruz
spelling Drug susceptibility of Brazilian strains of Mycobacterium bovis using traditional and molecular techniquesMycobacterium bovisdrug susceptibilityisoniaziderifoligotypingTransmission of Mycobacterium bovis from cattle to humans has been reported and can cause tuberculosis (Tb) and a problem in certain risk populations. Therefore, knowledge of resistance of M. bovis towards antibiotics used for therapy of human Tb could help avoiding cure delay and treatment cost increase when dealing with drug resistant organisms. We therefore evaluated the susceptibility of M. bovis isolates towards streptomycin, isoniazide, rifampicin, ethambutol, and ethionamide, the first line antibiotics for human Tb. Therefore, 185 clinical samples from cattle with clinical signs of tuberculosis were processed and submitted to culturing and bacterial isolates to identification and drug susceptibility testing using the proportion method. Among 89 mycobacterial strains, 65 were identified as M. bovis and none were resistant to any of the antibiotics used. Confirmation of present results by future studies, enrolling a large number of isolates and designed to properly represent Brazilian regions, may favor the idea of using isoniazide preventive therapy as part of a Tb control strategy in special situations. Also, nucleic acids from bacterial isolates were submitted to rifoligotyping, a recently described reverse hybridization assay for detection of mutations causing resistance towards rifampicin. Concordance between the conventional and the molecular test was 100%, demonstrating the use of such methodology for rapid evaluation of drug susceptibility in M. bovis.Instituto Oswaldo Cruz, Ministério da Saúde2004-11-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762004000700015Memórias do Instituto Oswaldo Cruz v.99 n.7 2004reponame:Memórias do Instituto Oswaldo Cruzinstname:Fundação Oswaldo Cruzinstacron:FIOCRUZ10.1590/S0074-02762004000700015info:eu-repo/semantics/openAccessParreiras,Patrícia MLobato,Francisco CFAlencar,Andréa PFigueiredo,Telma deGomes,Harrison MBoéchat,NeioLage,Andrey PAssis,Ronnie APereira,Márcia ASSouza,Patrícia RMota,Pedro MPCSuffys,Philip Neng2020-04-25T17:49:20Zhttp://www.scielo.br/oai/scielo-oai.php0074-02761678-8060opendoar:null2020-04-26 02:12:49.641Memórias do Instituto Oswaldo Cruz - Fundação Oswaldo Cruztrue
dc.title.none.fl_str_mv Drug susceptibility of Brazilian strains of Mycobacterium bovis using traditional and molecular techniques
title Drug susceptibility of Brazilian strains of Mycobacterium bovis using traditional and molecular techniques
spellingShingle Drug susceptibility of Brazilian strains of Mycobacterium bovis using traditional and molecular techniques
Parreiras,Patrícia M
Mycobacterium bovis
drug susceptibility
isoniazide
rifoligotyping
title_short Drug susceptibility of Brazilian strains of Mycobacterium bovis using traditional and molecular techniques
title_full Drug susceptibility of Brazilian strains of Mycobacterium bovis using traditional and molecular techniques
title_fullStr Drug susceptibility of Brazilian strains of Mycobacterium bovis using traditional and molecular techniques
title_full_unstemmed Drug susceptibility of Brazilian strains of Mycobacterium bovis using traditional and molecular techniques
title_sort Drug susceptibility of Brazilian strains of Mycobacterium bovis using traditional and molecular techniques
author Parreiras,Patrícia M
author_facet Parreiras,Patrícia M
Lobato,Francisco CF
Alencar,Andréa P
Figueiredo,Telma de
Gomes,Harrison M
Boéchat,Neio
Lage,Andrey P
Assis,Ronnie A
Pereira,Márcia AS
Souza,Patrícia R
Mota,Pedro MPC
Suffys,Philip N
author_role author
author2 Lobato,Francisco CF
Alencar,Andréa P
Figueiredo,Telma de
Gomes,Harrison M
Boéchat,Neio
Lage,Andrey P
Assis,Ronnie A
Pereira,Márcia AS
Souza,Patrícia R
Mota,Pedro MPC
Suffys,Philip N
author2_role author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Parreiras,Patrícia M
Lobato,Francisco CF
Alencar,Andréa P
Figueiredo,Telma de
Gomes,Harrison M
Boéchat,Neio
Lage,Andrey P
Assis,Ronnie A
Pereira,Márcia AS
Souza,Patrícia R
Mota,Pedro MPC
Suffys,Philip N
dc.subject.por.fl_str_mv Mycobacterium bovis
drug susceptibility
isoniazide
rifoligotyping
topic Mycobacterium bovis
drug susceptibility
isoniazide
rifoligotyping
dc.description.none.fl_txt_mv Transmission of Mycobacterium bovis from cattle to humans has been reported and can cause tuberculosis (Tb) and a problem in certain risk populations. Therefore, knowledge of resistance of M. bovis towards antibiotics used for therapy of human Tb could help avoiding cure delay and treatment cost increase when dealing with drug resistant organisms. We therefore evaluated the susceptibility of M. bovis isolates towards streptomycin, isoniazide, rifampicin, ethambutol, and ethionamide, the first line antibiotics for human Tb. Therefore, 185 clinical samples from cattle with clinical signs of tuberculosis were processed and submitted to culturing and bacterial isolates to identification and drug susceptibility testing using the proportion method. Among 89 mycobacterial strains, 65 were identified as M. bovis and none were resistant to any of the antibiotics used. Confirmation of present results by future studies, enrolling a large number of isolates and designed to properly represent Brazilian regions, may favor the idea of using isoniazide preventive therapy as part of a Tb control strategy in special situations. Also, nucleic acids from bacterial isolates were submitted to rifoligotyping, a recently described reverse hybridization assay for detection of mutations causing resistance towards rifampicin. Concordance between the conventional and the molecular test was 100%, demonstrating the use of such methodology for rapid evaluation of drug susceptibility in M. bovis.
description Transmission of Mycobacterium bovis from cattle to humans has been reported and can cause tuberculosis (Tb) and a problem in certain risk populations. Therefore, knowledge of resistance of M. bovis towards antibiotics used for therapy of human Tb could help avoiding cure delay and treatment cost increase when dealing with drug resistant organisms. We therefore evaluated the susceptibility of M. bovis isolates towards streptomycin, isoniazide, rifampicin, ethambutol, and ethionamide, the first line antibiotics for human Tb. Therefore, 185 clinical samples from cattle with clinical signs of tuberculosis were processed and submitted to culturing and bacterial isolates to identification and drug susceptibility testing using the proportion method. Among 89 mycobacterial strains, 65 were identified as M. bovis and none were resistant to any of the antibiotics used. Confirmation of present results by future studies, enrolling a large number of isolates and designed to properly represent Brazilian regions, may favor the idea of using isoniazide preventive therapy as part of a Tb control strategy in special situations. Also, nucleic acids from bacterial isolates were submitted to rifoligotyping, a recently described reverse hybridization assay for detection of mutations causing resistance towards rifampicin. Concordance between the conventional and the molecular test was 100%, demonstrating the use of such methodology for rapid evaluation of drug susceptibility in M. bovis.
publishDate 2004
dc.date.none.fl_str_mv 2004-11-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762004000700015
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762004000700015
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/S0074-02762004000700015
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Instituto Oswaldo Cruz, Ministério da Saúde
publisher.none.fl_str_mv Instituto Oswaldo Cruz, Ministério da Saúde
dc.source.none.fl_str_mv Memórias do Instituto Oswaldo Cruz v.99 n.7 2004
reponame:Memórias do Instituto Oswaldo Cruz
instname:Fundação Oswaldo Cruz
instacron:FIOCRUZ
reponame_str Memórias do Instituto Oswaldo Cruz
collection Memórias do Instituto Oswaldo Cruz
instname_str Fundação Oswaldo Cruz
instacron_str FIOCRUZ
institution FIOCRUZ
repository.name.fl_str_mv Memórias do Instituto Oswaldo Cruz - Fundação Oswaldo Cruz
repository.mail.fl_str_mv
_version_ 1669937691799584768